We share our outcomes with you

Choosing where to bring your child for care is a major decision. We understand you want all the information you can get. And you want it in a clear, straightforward form that helps you make the right choice for your family.

That’s why we share our outcomes with you. In medicine, “outcomes” measure the end results of a treatment. By comparing our outcomes with those of other hospitals, locally and nationally, you can see how we rank in terms of keeping patients safe and healthy.

See how Children’s ranks on six quality of care measures. Learn more.

Finding new ways to improve comfort and care

At Children’s, we focus on research and innovations that make a difference at the bedside. From improving day-to-day quality of life for children and teens, to developing new pain management approaches and adopting cutting-edge technologies, our research is completely kid-and-family focused.

Internationally known Daniel Le Grange, PhD, eating disorders director in the child and adolescent psychiatry division of psychiatry and pediatrics at the University of California, San Francisco (USCF) is a research consultant to Children’s working on an effectiveness trial comparing family based therapy to CBT-E for adolescents, and assisting with assessing all eating disorder patients and tracking our outcomes.

Clinical Outcomes Evaluation Project

Two specific treatments have emerged as the leading evidence-based treatments: 1) family-based therapy (FBT) for children and adolescents, and 2) enhanced cognitive behavioral therapy (CBT-E) for adults. Evidence suggests that CBT-E is also effective in treating adolescents. At the Center for the Treatment of Eating Disorders, all clinicians have been trained in FBT and CBT-E (as well as our other offered treatments) and receive ongoing consultation from the developers of these treatments.

We’re currently conducting the Clinical Outcomes Evaluation Project with the goal of developing a database that will allow us to carefully track treatment outcomes in a clinical (that is, real-world) setting, as opposed to a controlled setting.

Tracking outcomes is important to ensure we are providing the highest quality of care to our patients. Through this study, we’re looking at the proportion of our patients for whom each treatment approach is effective and reporting recovery rates for each specific therapy. Each patient is assessed at the beginning of treatment and at 20-week intervals. We use the assessments both to inform our ongoing patient care as well as to measure progress.

To examine longer-term treatment effectiveness, we conduct follow-up assessments with patients six months to one year after the end of treatment. We define response to treatment in terms of body mass index (BMI) and measures of symptoms of eating disorders, clinical impairment, depression and anxiety. We also assess change in factors that are thought to influence response to treatment and risk for relapse, such as perfectionism, self-esteem and the emotional climate of the family.

Learn more about research at Children’s.



At Children’s, we know how important reliable information about conditions and illnesses is.